Xintela
Manufacturing · Sweden · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Scheeletorget 1, Lund, Skane, 223 81, Sw...Phone Number
+46 462756500Website
www.xintela.seRevenue
$6.5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Xintela
Xintela AB is a biopharmaceutical company focused on regenerative medicine and cancer therapies, specifically targeting the development of new treatments for conditions with significant medical needs, such as cartilage damage and brain tumors. The company specializes in stem cell therapies and targeted cancer therapies. Xintela aims to address critical health challenges through innovative solutions in the biomedical field. Their intended clients include patients suffering from severe medical conditions requiring advanced treatment options.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Xintela your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Xintela has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Xintela launches new products
Website visits: Recent activity has been detected on your website
Xintela, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Xintela is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Xintela
Earning: See what the market has to say on Xintela recently announced quarterly report
Funding: Get notified immidiatlly once Xintela has new funding data
Click to see if Xintela had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Xintela is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Xintela is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Xintela.
Xintela Tech Stack
A closer look at the technologies used by Xintela
See more technologies
Xintela News & Media
BioStock: Xintela initiates last dose level in knee osteoarthritis study
Xintela recently announced that they have initiated the third and last dose level in the phase I/IIa study with the stem cell product XSTEM in patients with knee osteoarthritis. The company’s goal is to present safety data from all dose levels and early efficacy results in 2023. BioStock contacted Camilla Wennersten, Director Clinical Development at Xintela, to find out more about the study. Read the full article at biostock.se: https://www.biostock.se/en/2023/05/xintela-initiates-last-dose-leveNew board of directors appointed in Targ | MarketScreener
Press release October 29, 2021 New board of directors appointed in Targinta AB #Regulatory XintelaBioStock: New CEO for Xintela's subsidiary Targinta
Xintela recently achieved an important milestone towards the goal of spinning out its subsidiary Targinta when Per Norlén was recruited as CEO and CMO for the company. Norlén has vast experience in early-stage drug development and antibody-based cancer drugs, which will be very useful in Targinta. BioStock reached out to Per Norlén to hear his thoughts on his mission to lead and develop Targinta. Read the full article at biostock.se: https://www.biostock.se/en/new-ceo-for-xintelas-subsidiary-tarIs Xintela AB (publ)'s (STO:XINT) CEO Paid Enough Relative To Peers?
Evy Lundgren-Åkerlund has been the CEO of Xintela AB (publ) (STO:XINT) since 2009. First, this article will compare...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Xintela
Sign Up For FreeTo access detailed company insights
Xintela AB is a biopharmaceutical company focused on regenerative medicine and cancer therapies, specifically targeting the development of new treatments for conditions with significant medical needs, such as cartilage damage and brain tumors. The company specializes in stem cell therapies and targeted cancer therapies. Xintela aims to address crit... Read More
